JSPR Cash-Secured Put Strategy
JSPR (Jasper Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside the body prior to transplantation. The company's lead product candidate is JSP191, which is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.
JSPR (Jasper Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $15.0M, a beta of 3.08 versus the broader market, a 52-week range of 0.623-7.19, average daily share volume of 415K, a public-listing history dating back to 2020, approximately 64 full-time employees. These structural characteristics shape how JSPR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 3.08 indicates JSPR has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a cash-secured put on JSPR?
A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.
Current JSPR snapshot
As of May 15, 2026, spot at $0.83, ATM IV 27.40%, IV rank 2.73%, expected move 7.86%. The cash-secured put on JSPR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this cash-secured put structure on JSPR specifically: JSPR IV at 27.40% is on the cheap side of its 1-year range, which means a premium-selling JSPR cash-secured put collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 7.86% (roughly $0.07 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated JSPR expiries trade a higher absolute premium for lower per-day decay. Position sizing on JSPR should anchor to the underlying notional of $0.83 per share and to the trader's directional view on JSPR stock.
JSPR cash-secured put setup
The JSPR cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With JSPR near $0.83, the first option leg uses a $0.79 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed JSPR chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 JSPR shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Sell 1 | Put | $0.79 | N/A |
JSPR cash-secured put risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.
JSPR cash-secured put payoff curve
Modeled P&L at expiration across a range of underlying prices for the cash-secured put on JSPR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use cash-secured put on JSPR
Cash-secured puts on JSPR earn premium while a trader waits to acquire JSPR stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning JSPR.
JSPR thesis for this cash-secured put
The market-implied 1-standard-deviation range for JSPR extends from approximately $0.76 on the downside to $0.90 on the upside. A JSPR cash-secured put lets a trader earn premium while waiting to acquire JSPR at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current JSPR IV rank near 2.73% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on JSPR at 27.40%. As a Healthcare name, JSPR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to JSPR-specific events.
JSPR cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. JSPR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move JSPR alongside the broader basket even when JSPR-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on JSPR carry tail risk when realized volatility exceeds the implied move; review historical JSPR earnings reactions and macro stress periods before sizing. Always rebuild the position from current JSPR chain quotes before placing a trade.
Frequently asked questions
- What is a cash-secured put on JSPR?
- A cash-secured put on JSPR is the cash-secured put strategy applied to JSPR (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With JSPR stock trading near $0.83, the strikes shown on this page are snapped to the nearest listed JSPR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are JSPR cash-secured put max profit and max loss calculated?
- Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the JSPR cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 27.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a JSPR cash-secured put?
- The breakeven for the JSPR cash-secured put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current JSPR market-implied 1-standard-deviation expected move is approximately 7.86%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a cash-secured put on JSPR?
- Cash-secured puts on JSPR earn premium while a trader waits to acquire JSPR stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning JSPR.
- How does current JSPR implied volatility affect this cash-secured put?
- JSPR ATM IV is at 27.40% with IV rank near 2.73%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.